Literature DB >> 24023600

History of BCG Vaccine.

Simona Luca1, Traian Mihaescu.   

Abstract

Tuberculosis (TB) is still responsible for 2 million deaths every year despite being a treatable airborne infectious disease. "Consumption" and "Phthisis" were terms historically used to describe TB, which was responsible for one in four deaths in the 19th century. Due to its infectious nature, chronic progression and long treatment, TB is a great burden for society. Moreover the emergence of multi-drug resistant TB and the current TB-HIV epidemic has raised even greater concern. Treating and preventing TB has become a permanent challange since the ancient times. Bacille Calmette-Guérin (BCG) is the only vaccine available today and has been used for more than 90 years with astonishing safety records. However, its efficacy remains controversial. No universal BCG vaccination policy exists, with some countries merely recommending its use and others that have implemented immunization programs. In this article we review several important milestones of BCG vaccine development from the discovery till today.

Entities:  

Keywords:  BCG; Tuberculosis; history; review; vaccine

Year:  2013        PMID: 24023600      PMCID: PMC3749764     

Source DB:  PubMed          Journal:  Maedica (Bucur)        ISSN: 1841-9038


  22 in total

1.  The influence of bacille Calmette-Guerin vaccine strain on the immune response against tuberculosis: a randomized trial.

Authors:  Nicole Ritz; Binita Dutta; Susan Donath; Dan Casalaz; Tom G Connell; Marc Tebruegge; Roy Robins-Browne; Willem A Hanekom; Warwick J Britton; Nigel Curtis
Journal:  Am J Respir Crit Care Med       Date:  2011-11-03       Impact factor: 21.405

2.  Report on a WHO consultation on the characterisation of BCG strains, Imperial College, London 15-16 December 2003.

Authors:  M J Corbel; U Fruth; E Griffiths; Ivana Knezevic
Journal:  Vaccine       Date:  2004-07-29       Impact factor: 3.641

Review 3.  New vaccines for tuberculosis.

Authors:  Stefan H E Kaufmann; Gregory Hussey; Paul-Henri Lambert
Journal:  Lancet       Date:  2010-05-18       Impact factor: 79.321

Review 4.  Changing funding patterns in tuberculosis.

Authors:  Stefan H E Kaufmann; Shreemanta K Parida
Journal:  Nat Med       Date:  2007-03       Impact factor: 53.440

5.  Overcoming the global crisis: "yes, we can", but also for TB ... ?

Authors:  Tom H M Ottenhoff
Journal:  Eur J Immunol       Date:  2009-08       Impact factor: 5.532

6.  Long-term results of BCG vaccination in the southern United States.

Authors:  G W Comstock; C E Palmer
Journal:  Am Rev Respir Dis       Date:  1966-02

7.  Effects of infection with atypical mycobacteria on BCG vaccination and tuberculosis.

Authors:  C E Palmer; M W Long
Journal:  Am Rev Respir Dis       Date:  1966-10

8.  BCG and vole bacillus vaccines in the prevention of tuberculosis in adolescence and early adult life.

Authors:  P D Hart; I Sutherland
Journal:  Br Med J       Date:  1977-07-30

9.  Deciphering the biology of Mycobacterium tuberculosis from the complete genome sequence.

Authors:  S T Cole; R Brosch; J Parkhill; T Garnier; C Churcher; D Harris; S V Gordon; K Eiglmeier; S Gas; C E Barry; F Tekaia; K Badcock; D Basham; D Brown; T Chillingworth; R Connor; R Davies; K Devlin; T Feltwell; S Gentles; N Hamlin; S Holroyd; T Hornsby; K Jagels; A Krogh; J McLean; S Moule; L Murphy; K Oliver; J Osborne; M A Quail; M A Rajandream; J Rogers; S Rutter; K Seeger; J Skelton; R Squares; S Squares; J E Sulston; K Taylor; S Whitehead; B G Barrell
Journal:  Nature       Date:  1998-06-11       Impact factor: 49.962

10.  Molecular analysis of genetic differences between Mycobacterium bovis BCG and virulent M. bovis.

Authors:  G G Mahairas; P J Sabo; M J Hickey; D C Singh; C K Stover
Journal:  J Bacteriol       Date:  1996-03       Impact factor: 3.490

View more
  85 in total

1.  New insights into the host cell necrosis in tuberculosis.

Authors:  Marko Pesu
Journal:  Virulence       Date:  2015-11-25       Impact factor: 5.882

Review 2.  Prospects in Mycobacterium bovis Bacille Calmette et Guérin (BCG) vaccine diversity and delivery: why does BCG fail to protect against tuberculosis?

Authors:  Juan I Moliva; Joanne Turner; Jordi B Torrelles
Journal:  Vaccine       Date:  2015-08-28       Impact factor: 3.641

3.  The Legacy of Robert Koch: Surmise, search, substantiate.

Authors:  Ritu Lakhtakia
Journal:  Sultan Qaboos Univ Med J       Date:  2014-01-27

Review 4.  Mycobacterium tuberculosis bacteremia in adults and children: a systematic review and meta-analysis.

Authors:  P B Pavlinac; E M Lokken; J L Walson; B A Richardson; J A Crump; G C John-Stewart
Journal:  Int J Tuberc Lung Dis       Date:  2016-07       Impact factor: 2.373

Review 5.  Life-Threatening Infections Due to Live-Attenuated Vaccines: Early Manifestations of Inborn Errors of Immunity.

Authors:  Laura Pöyhönen; Jacinta Bustamante; Jean-Laurent Casanova; Emmanuelle Jouanguy; Qian Zhang
Journal:  J Clin Immunol       Date:  2019-05-23       Impact factor: 8.317

6.  Stable Expression of Lentiviral Antigens by Quality-Controlled Recombinant Mycobacterium bovis BCG Vectors.

Authors:  Bryan E Hart; Rose Asrican; So-Yon Lim; Jaimie D Sixsmith; Regy Lukose; Sommer J R Souther; Swati D G Rayasam; Joseph W Saelens; Ching-Ju Chen; Sarah A Seay; Linda Berney-Meyer; Leslie Magtanong; Kim Vermeul; Priyadharshini Pajanirassa; Amanda E Jimenez; Tony W Ng; David M Tobin; Steven A Porcelli; Michelle H Larsen; Joern E Schmitz; Barton F Haynes; William R Jacobs; Sunhee Lee; Richard Frothingham
Journal:  Clin Vaccine Immunol       Date:  2015-04-29

Review 7.  Novel Approaches for the Treatment of Pulmonary Tuberculosis.

Authors:  Zhi Ming Tan; Gui Ping Lai; Manisha Pandey; Teerapol Srichana; Mallikarjuna Rao Pichika; Bapi Gorain; Subrat Kumar Bhattamishra; Hira Choudhury
Journal:  Pharmaceutics       Date:  2020-12-10       Impact factor: 6.321

Review 8.  Understanding and overcoming the barriers to T cell-mediated immunity against tuberculosis.

Authors:  Kevin B Urdahl
Journal:  Semin Immunol       Date:  2014-10-28       Impact factor: 11.130

9.  Mosaic structure of Mycobacterium bovis BCG genomes as a representation of phage sequences' mobility.

Authors:  Olga L Voronina; Marina S Kunda; Ekaterina I Aksenova; Andrey N Semenov; Natalia N Ryzhova; Vladimir G Lunin; Alexandr L Gintsburg
Journal:  BMC Genomics       Date:  2016-12-28       Impact factor: 3.969

Review 10.  BCG: a vaccine with multiple faces.

Authors:  Marco Antonio Yamazaki-Nakashimada; Alberto Unzueta; Luisa Berenise Gámez-González; Napoleón González-Saldaña; Ricardo U Sorensen
Journal:  Hum Vaccin Immunother       Date:  2020-01-29       Impact factor: 3.452

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.